[Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Jingbo Su(Xijing Hospital), Zhaohui Tang(XinHua Hospital), J W Zhang(Northwestern Polytechnical University), Yinghe Qiu(Second Military Medical University), Bambang Budi Siswanto(Northwestern Polytechnical University), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Zhiqiang Cai(Northwestern Polytechnical University), C Chen(First Affiliated Hospital of Xi'an Jiaotong University), Zhangjun Cheng(Zhongda Hospital Southeast University), Yanyan He(Army Medical University), Wu H(Tongji University), X H Mao(Hunan Provincial People's Hospital), Zhimin Geng(Children's Hospital of Zhejiang University), J D Li(GlaxoSmithKline (China)), Wenlong Zhai(Zhengzhou University)
Cited by 1
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Ferroptosis-related Genes for Overall Survival Prediction in Patients with Colorectal Cancer can be Inhibited by Gallic acid
|International Journal of Biological Sciences|2021|74
NSUN2-Mediated mRNA m <b>5</b> C Modification Regulates the Progression of Hepatocellular Carcinoma
|Genomics Proteomics & Bioinformatics|2022|72